During the observed time period from June 1, 2016, until May 31, 2017, Rega was deployed for a total of 9,035 missions. The 2,428 secondary missions were excluded and the remaining 6,607 primary missions were potentially eligible for analysis. In 927 missions, some type of airway management was identified. In 251 of those cases, it was short-term assisted ventilation using only bag-valve mask ventilation. A total of 676 patients received invasive airway management, completing the study cohort (Fig. 1).
The mean age of the patients was 54.6 ± 21.8 years and the majority of patients were male (72.9%). There were no significant differences in these baseline characteristics between patients with difficult airways and patients with non-difficult airways. In a total of 44 patients (6.5% of patients with invasive ventilatory support), difficulties in airway management were reported.
In the 335 patients whose airway was managed by GEMS, intubation failed in 19 (5.5%), in 76 (22.5%) cases the crew used a supraglottic device or bag valve mask (BVM) and was successful in 240 (72%) (Fig. 1). There were no reports available regarding the number of intubation attempts made by GEMS.
There were 341 patients whose airway was managed by Rega HEMS. Intubation failed initially in 25 of these patients and was successful in 316. In addition, Rega physicians solved the airway management difficulties of 20 GEMS patients, using standard intubation in a second attempt. This resulted in a failure rate of 6.9% (25/361) and an HEMS first-attempt success rate of 93%.
The Rega team solved the airway management difficulties using standard intubation (successful intubation on a second attempt) in 24 patients. In six patients 2nd attempt intubation was successful using a special device a bougie, BVM ventilation in 4 patients, intubation via Intubating Laryngeal Mask (ILMA, Teleflex, Westmeath, Ireland) in 3 patients and performing a futile cricotomy in one patient. In 6 patients, the supraglottic airway device was left in place (Fig. 1).
Airway management in paediatric patients (n = 39) was uneventful in 6 cases (age 0–1 years), 18 cases (2–6 years) and 15 cases (7–15 years). A supraglottic airway device was used as a primary device in 55 patients when the GEMS was not staffed by a crew competent in ETI. Twenty-two of these patients were later intubated by Rega personnel, and in 33 patients the supraglottic airway device was left in place until arrival at the hospital.
The most common condition requiring any form of airway management was trauma (39.9%), followed by cardiovascular emergencies (33.9%) and neurological emergencies (16.6%). The median NACA score was 5 (IQR 5 to 6) and was not significantly different among the groups, p = 0.94. The use of catecholamines was associated with fewer difficulties in airway management in both the univariate and the multivariate analysis (p = 0.048). Trauma was associated with more difficulties in airway management than cardiovascular disease, but only in the multivariate analysis (p = 0.021). There was no significant difference in all other baseline characteristics in both the univariate and the multivariate analyses (Tables 1 and 2, Fig. 3). The use of neuromuscular blocking agents to facilitate tracheal intubation was reported in only 390 (66%) patients and was not available for 286 patients. Succinylcholine was used in 176 patients (45.1%), rocuronium in 107 patients (27.4%), and no neuromuscular blocking agents (NMBA) in 107 patients (27.4%). The absence of NMBA was found significantly more often (p < 0.001) in patients undergoing CPR than in the remaining patients.
Table 1
Variable | Successful First Attempt Intubation N = 632 | Difficult Airway N = 44 | Total N = 676 | p value |
Age, years mean (SD) | 54.9 (21.8) | 51.4 (20.8) | 54.6 (21.8) | 0.305 |
Male sex | 460 (72.8%) | 33 (75.0%) | 493 (72.9%) | 0.749 |
Diagnosis | | | | 0.056 |
Trauma | 244 (38.6%) | 26 (59.1%) | 270 (39.9%) | |
Cardiovascular | 219 (34.7%) | 10 (22.7%) | 229 (33.9%) | |
Neurological | 106 (16.8%) | 6 (13.6%) | 112 (16.6%) | |
Other | 63 (10.0%) | 2 (4.5%) | 65 (9.6%) | |
CPR | 175 (27.7%) | 10 (22.7%) | 185 (27.4%) | 0.475 |
NACA | | | | 0.935 |
Median | 5 | 5 | 5 | |
IQR | 5 to 6 | 5 to 6 | 5 to 6 | |
Use of NMBA | 412 (65.2%) | 31 (70.5%) | 443 (65.5%) | 0.477 |
Type of NMBA | | | | 0.659 |
Missing | 275 | 11 | 286 | |
None | 100 (28.0%) | 7 (21.2%) | 107 (27.4%) | |
Succinylcholine | 159 (44.5%) | 17 (51.5%) | 176 (45.1%) | |
Rocuronium | 98 (27.5%) | 9 (27.3%) | 107 (27.4%) | |
Use of catecholamines | 254 (40.2%) | 11 (25.0%) | 265 (39.2%) | 0.046 |
Night-time Mission | 81 (12.8%) | 8 (18.2%) | 89 (13.2%) | 0.309 |
Remote Location | 105 (16.6%) | 4 (9.1%) | 109 (16.1%) | 0.190 |
Data was complete if not otherwise stated. CPR=cardiopulmonary resuscitation. IQR: Interquartile Range. NMBA=neuromuscular blocking agents
Table 2
Variable | Odds Ratio | 95% C.I. | p value |
Age, years | 1.00 | 0.99–1.02 | 0.991 |
Male sex | 1.04 | 0.51–2.24 | 0.926 |
Cardiovascular diagnosis | 0.34 | 0.13–0.84 | 0.021 |
Neurological diagnosis | 0.59 | 0.21–1.48 | 0.286 |
Other diagnosis | 0.27 | 0.04–0.97 | 0.086 |
Remote location | 0.49 | 0.14–1.26 | 0.183 |
Night-time mission | 1.48 | 0.60–3.30 | 0.362 |
Use of NMBA | 1.26 | 0.52–3.32 | 0.627 |
Use of catecholamines | 0.45 | 0.19–0.97 | 0.048 |
CPR | 0.82 | 0.29–2.32 | 0.704 |
NACA | 1.82 | 0.99–3.39 | 0.057 |
Footnote: Complete case analysis of 676 patients. Pseudo-R² (Cragg-Uhler) = 0.06. Intercept OR = 0.00 (0.00 - 0.18) p= 0.005.
In the observed time period, a total of 137 different Rega physicians treated the patients who needed advanced airway support. Paramedics (n = 48) were significantly more involved than physicians in pre-hospital airway manoeuvres: median 12 (IQR 9 to 17.5) versus 3 (IQR 2 to 6), p < 0.001 (Fig. 2).